DR. BRANDON DAVID KONKEL M.D. NPI 1841637436

NPI Details

DR. Brandon David Konkel, M.D. is a medical oncology internal medicine in Sarasota, FL with 13 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Brandon David Konkel, M.D. NPI is 1841637436. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF COLORADO SCHOOL OF MEDICINE, DENVER
Graduation Year:2013

The provider's business location address is:

1970 GOLF ST
SARASOTA, FL
ZIP 34236-908
Phone: (941) 957-1000
Fax: (941) 951-2117

The NPI 1841637436 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Ferritin (blood protein) level (HCPCS:82728)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Iron level (HCPCS:83540)
• Protein measurement, serum (HCPCS:84165)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection of drug or substance into vein (HCPCS:96374)
• Folic acid level, serum (HCPCS:82746)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Iron binding capacity (HCPCS:83550)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Magnesium level (HCPCS:83735)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Erythropoietin (protein) level (HCPCS:82668)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
• Automated urinalysis test (HCPCS:81003)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Blood test, clotting time (HCPCS:85610)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Hepatitis b core antibody (igm) measurement (HCPCS:86705)
• Liver function blood test panel (HCPCS:80076)
• Hepatitis c antibody measurement (HCPCS:86803)
• Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous (HCPCS:G0328)

The enumeration date for this NPI number is 5/23/2013 and was last updated on 8/9/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.